» Articles » PMID: 35371310

MiR-145-5p Inhibits the Proliferation of Glioma Stem Cells by Targeting Translationally Controlled Tumor Protein

Overview
Journal J Cancer
Specialty Oncology
Date 2022 Apr 4
PMID 35371310
Authors
Affiliations
Soon will be listed here.
Abstract

Glioma stem cells (GSCs) have potential for proliferation, self-renewal, and differentiation-the properties that play decisive roles in the process of malignancy in glioma. MicroRNAs (miRNAs) have been shown to regulate the characteristics of cancer stem cells. In this study, we show that miR-145-5p, a recently discovered miRNA, is expressed at low levels in primary GSCs (pGSCs). Upregulation of miR-145-5p resulted in the inhibition of proliferation and increased apoptosis of pGSCs. Furthermore, its overexpression resulted in reduced expression of translationally controlled tumor protein (TCTP). Bioinformatics analysis and luciferase targeting assay revealed that miR-145-5p exerts its effects by directly targeting TCTP. The expression of TCTP was significantly upregulated in pGSCs, and its silencing suppressed the proliferation and increased the apoptosis of pGSCs. Moreover, upregulation of TCTP attenuated the effect of miR-145-5p overexpression on the viability and apoptosis of pGSCs. The results of studies were corroborated using an orthotopic mouse model. Taken together, these results suggest that miR-145-5p could be a novel therapeutic target for gliomas through the suppression of TCTP in GSCs.

Citing Articles

Role of miRNA‑145‑5p in cancer (Review).

Chen Z, Qin Y Oncol Rep. 2025; 53(3).

PMID: 39886965 PMC: 11800069. DOI: 10.3892/or.2025.8872.


Understanding the molecular mechanism of regeneration through apoptosis-induced compensatory proliferation studies - updates and future aspects.

Rajagopalan K, Selvan Christyraj J, Subbiahanadar Chelladurai K, Kalimuthu K, Das P, Chandrasekar M Apoptosis. 2024; 29(9-10):1399-1414.

PMID: 38581530 DOI: 10.1007/s10495-024-01958-1.


Circular RNA MTCL1 targets SMAD3 by sponging miR-145-5p for regulation of cell proliferation and migration in Hirschsprung's disease.

Chen W, Caiyun L, Yang Y, Xinwei H, Nan L, Jiaming Y Pediatr Surg Int. 2023; 40(1):25.

PMID: 38127107 DOI: 10.1007/s00383-023-05621-9.


Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy.

Santamaria G, Cioce M, Rizzuto A, Fazio V, Viglietto G, Lucibello M Cancer Drug Resist. 2023; 6(3):447-467.

PMID: 37842235 PMC: 10571059. DOI: 10.20517/cdr.2023.21.

References
1.
Witthayanuwat S, Pesee M, Supaadirek C, Supakalin N, Thamronganantasakul K, Krusun S . Survival Analysis of Glioblastoma Multiforme. Asian Pac J Cancer Prev. 2018; 19(9):2613-2617. PMC: 6249474. DOI: 10.22034/APJCP.2018.19.9.2613. View

2.
Saadatpour L, Fadaee E, Fadaei S, Nassiri Mansour R, Mohammadi M, Mousavi S . Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther. 2016; 23(12):415-418. DOI: 10.1038/cgt.2016.48. View

3.
Baylot V, Karaki S, Rocchi P . TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression. Results Probl Cell Differ. 2017; 64:255-261. DOI: 10.1007/978-3-319-67591-6_13. View

4.
Xu D, Guo J, Zhu G, Wu H, Zhang Q, Cui T . MiR-363-3p modulates cell growth and invasion in glioma by directly targeting pyruvate dehydrogenase B. Eur Rev Med Pharmacol Sci. 2018; 22(16):5230-5239. DOI: 10.26355/eurrev_201808_15721. View

5.
Shi L, Wang Z, Sun G, Wan Y, Guo J, Fu X . miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Neuromolecular Med. 2014; 16(2):517-28. DOI: 10.1007/s12017-014-8305-y. View